Kira Scherer Wampler Sells 2,000 Shares of Doximity (NYSE:DOCS) Stock

Doximity, Inc. (NYSE:DOCS) Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $24.95, for a total value of $49,900.00. Following the transaction, the director owned 19,839 shares of the company’s stock, valued at $494,983.05. This trade represents a 9.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Doximity Price Performance

Shares of DOCS stock opened at $26.74 on Friday. The stock’s fifty day simple moving average is $22.71 and its 200 day simple moving average is $23.08. The firm has a market cap of $4.77 billion, a price-to-earnings ratio of 31.46, a P/E/G ratio of 20.02 and a beta of 1.29. Doximity, Inc. has a one year low of $17.15 and a one year high of $76.51.

Doximity (NYSE:DOCS) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.13. The firm had revenue of $156.62 million during the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The business’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.36 earnings per share. On average, research analysts anticipate that Doximity, Inc. will post 0.74 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. California State Teachers Retirement System grew its holdings in Doximity by 1,908.5% during the 2nd quarter. California State Teachers Retirement System now owns 2,892,193 shares of the company’s stock worth $59,984,000 after acquiring an additional 2,748,192 shares during the last quarter. Carmignac Gestion raised its stake in shares of Doximity by 127.8% in the first quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after acquiring an additional 2,418,971 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of Doximity by 3,403.2% in the first quarter. SG Americas Securities LLC now owns 1,408,597 shares of the company’s stock worth $32,820,000 after acquiring an additional 1,368,388 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of Doximity by 325,436.6% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock worth $57,515,000 after acquiring an additional 1,298,492 shares during the last quarter. Finally, Federated Hermes Inc. lifted its position in shares of Doximity by 3,422.7% during the fourth quarter. Federated Hermes Inc. now owns 1,249,085 shares of the company’s stock worth $55,309,000 after purchasing an additional 1,213,627 shares in the last quarter. 87.19% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Needham & Company LLC reiterated a “buy” rating and set a $41.00 target price on shares of Doximity in a research report on Friday, August 7th. Canaccord Genuity Group set a $36.00 price target on shares of Doximity in a research report on Friday, August 7th. Leerink Partners dropped their price objective on shares of Doximity from $31.00 to $25.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. Robert W. Baird reiterated a “neutral” rating and issued a $18.00 target price (down from $40.00) on shares of Doximity in a research note on Thursday, May 14th. Finally, Zacks Research raised Doximity from a “strong sell” rating to a “hold” rating in a report on Monday, July 13th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $32.43.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.